Miyazaki Taiyo Capital-backed MabGenesis lists on Tokyo Stock Exchange Growth Market

Bitget2026/11/02 01:22

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

MabGenesis listed on the Tokyo Stock Exchange Growth Market on November 2, 2026, under securities code 653A.
Miyazaki Taiyo Capital backs the biotech company through its Miyazaki Future Support No. 2 and No. 3 funds.
The Yokohama-based company develops antibody drugs for humans and pets using research from Miyazaki University and Fujita Health University.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Miyazaki Taiyo Capital Ltd published the original content used to generate this news brief on November 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.

华尔街见闻•2026/11/09 10:26